Company News for Nov 17, 2025

Shares of Spire Inc. (SR) declined 2.4% after the company reported a fourth-quarter fiscal 2025 loss of $0.47 per share, wider than the Zacks Consensus Estimate of a loss of $0.46 per share.CG Oncology, Inc.’s (CGON) shares jumped 8.6% after the company reported third-quarter 2025 revenues of $1.67 million, beating the Zacks Consensus Estimate of $0.33 million. Shares of Globant S.A. (GLOB) fell 2.8% after the company reported third-quarter 2025 earnings of $1.53 per share, missing the Zacks Consensus Estimate of $1.54 per share. Nu Holdings Ltd.’s (NU) shares gained 1.5% after the company reported third-quarter 2025 earnings of $0.17 per share, surpassing the Zacks Consensus Estimate of $0.15 per share.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nu Holdings Ltd. (NU): Free Stock Analysis Report Spire Inc. (SR): Free Stock Analysis Report Globant S.A. (GLOB): Free Stock Analysis Report CG Oncology, Inc. (CGON): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks